SHENZHEN, China, Jan. 5 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain
Drugstore Ltd. (NYSE: NPD) ("Nepstar" or "the Company"), the largest retail
drugstore chain in China based on the number of directly operated stores,
today announced the appointment of Mr. Ian Wade, a retail industry veteran
with an outstanding track record of success, as the Co-Chief Executive Officer.
Concurrently, the Company announced the appointment of Mr. William Weili Dai
as the new Chief Financial Officer. Both appointments will be effective on
January 5, 2009.
Formally with AS Watson as the Group Managing Director for 25 years, Mr.
Ian Wade managed one of the world's largest and fastest growing global retail
companies, with over 7,700 stores in 37 countries. During his tenure at AS
Watson, he turned the Hong Kong based business, which then had 16 stores, into
a highly profitable, international retail chain with extensive reach
throughout Asia and Europe. Under his leadership, Watson opened 270 stores in
mainland China and 400 stores in Taiwan, and launched groundbreaking
hypermarkets in mainland China. In addition, Mr. Wade also managed Watson's
retail operations and private label businesses in many countries in Europe.
Mr. William Weili Dai brings to Nepstar over 15 years of experience in
financial management and accounting. Prior to joining Nepstar, Mr. Dai was the
chief financial officer of MicroPort Medical, a leading medical device company
in China. From 1996 to 2006, Mr. Dai served as finance manager in charge of
China operations for three leading global companies, Mundipharma
Pharmaceuticals, Boston Scientific and Case Corporation. During his tenure at
Mundipharma and Boston Scientific, he was involved in multiple strategic M&A
and business development projects in China. Mr. Dai began his financial
management career with Ford Motor Company in Michigan in 1993 as financial
analyst and later became the component department controller and then the
assistant to the CFO of Ford's joint venture in China. Mr. Dai received his
MBA from Michigan State University and his BA from Shanghai University.
"We are excited to welcome Mr. Wade and Mr. Dai to our management team.
With their breadth of experience, we are confident that they will be valuable
contributors to Nepstar," commented Mr. Simin Zhang, Chairman of China Nepstar.
Mr. Jiannong Qian, Co-Chief Executive Officer, will continue to focus on
new business development, acquisitions and partnership development, while Mr.
Wade will focus on maximizing operating efficiencies and profitable growth.
Upon the appointment of Mr. Dai, Mr. Zixin Shao, the interim Chief Financial
Officer, will resume his role as financial controller.
About China Nepstar Chain Drugstore Ltd.
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) is China's largest retail
drugstore chain based on the number of directly operated stores. As of
September 30, 2008, the Company had 2,667 stores across 76 cities, one
headquarters distribution center and 11 regional distribution centers in China.
Nepstar uses directly operated stores, centralized procurement and a network
of distribution centers to provide its customers with high-quality,
professional and convenient pharmacy services and a wide variety of other
merchandise, including OTC drugs, nutritional supplements, herbal products,
personal care products, family care products, and convenience products
including consumables. Nepstar's strategy of centralized procurement,
competitive pricing, customer loyalty programs and private label offerings has
enabled it to capitalize on the robust economic growth in China and to take
advantage of the demographic trend in China to achieve a strong brand and
leading market position. For further information, please go to
http://www.nepstar.cn .
Safe Harbor Statement
This press release contains forward-looking statements. These statements
constitute "forward-looking" statements within the meaning of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended, and as defined in the U.S. Private
Securities Litigation Reform Act of 1995. These forward-looking statements
can be identified by terminology such as "will," "expects," "anticipates,"
"future," "intends," "plans," "believes," "estimates" and similar statements.
Among other things, the quotations from management in this press release and
the Company's strategic operational plans, contain forward-looking statements.
Such statements involve certain risks and uncertainties that could cause
actual results to differ materially from those in the forward-looking
statements. Further information regarding these and other risks is included in
the Company's filings with the U.S. Securities and Exchange Commission,
including its annual report on Form 20-F. The Company does not undertake any
obligation to update any forward-looking statement as a result of new
information, future events or otherwise, except as required under applicable
law.
For more information, please contact:
In China:
Lucia Qian
China Nepstar Chain Drugstore Ltd.
Marketing and IR Director
Phone: +86-755-2641-4065
Email: qianrt@nepstar.cn
In the United States:
Dixon Chen
Grayling Global
Investor Relations
Tel: +1-646-284-9403
Email: dchen@hfgcg.com
Ivette Almeida
Grayling Global
Media Relations
Tel: +1-646-284-9455
Email: ialmeida@hfgcg.com
SOURCE China Nepstar Chain Drugstore Ltd.